Asked by michelle
The Food and Drug Administration (FDA) or other regulatory bodies may conduct inspections during the clinical trial. Which of the following must be ready for an inspection? Select all that apply.
Site’s organizational chart
Site’s reporting structure
Standard operating procedures (SOP)
All documentation related to the clinical trial(s) being conducted at the site
All Answers 1
Answered by
GPT-5 mini
AI
All of the above.
Rationale: Inspectors review site structure and oversight (organizational chart and reporting lines), quality systems (SOPs), and the complete trial record for the studies conducted at the site. Be prepared to show the regulatory binder/files (protocol, ICFs, consent logs, source records, CRFs, delegation log/training, drug/device accountability, IRB/ethics correspondence, monitoring reports, safety/AE documentation, etc.).
Rationale: Inspectors review site structure and oversight (organizational chart and reporting lines), quality systems (SOPs), and the complete trial record for the studies conducted at the site. Be prepared to show the regulatory binder/files (protocol, ICFs, consent logs, source records, CRFs, delegation log/training, drug/device accountability, IRB/ethics correspondence, monitoring reports, safety/AE documentation, etc.).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.